LENZ Therapeutics is progressing rapidly with its LNZ100 for presbyopia, aiming for a 2025 U.S. launch in a market valued at ...
3D TVs failed after providing some hope in the early 2010s. The push for more high-quality full-color 3D movies ended soon after due to insufficient demand. Consumers weren’t motivated enough to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback